14:10
Time-Restricted Eating · Ten-Hour Window
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
3 human trials, about 27 studies, ~600 participants. The written rationale for this grade is still being prepared.
- FDA
- Not a regulated intervention
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
Generally low for healthy adults, and gentler than tighter windows. Standard fasting cautions apply: people who are pregnant or breastfeeding, who have a history of disordered eating, who are underweight, or who take medications that depend on food timing such as insulin or certain blood-pressure or glucose-lowering drugs should not start without a clinician. If any of this touches you, the right next step is a conversation with your own healthcare provider, who can weigh your medications and history; this entry is descriptive and is not medical guidance or a how-to.
14:10 is a daily time-restricted eating pattern: a roughly 14-hour overnight fast leaving a ten-hour window for all food. It sits one step gentler than 16:8 and is often chosen for being livable. Its reputation rests heavily on Wilkinson 2020 in Cell Metabolism, which placed 19 metabolic-syndrome patients on a self-selected ten-hour window for 12 weeks and recorded lower weight, blood pressure, and atherogenic lipids. That study is a single-arm pilot with no control group, so it is a strong hypothesis generator rather than proof. Randomized trials that include a near-ten-hour window, plus broader TRE meta-analyses, are associated with modest improvements in weight, fasting glucose, and blood pressure, though much of the benefit may trace to eating somewhat less overall.
A gentle, sustainable middle ground, and the window with surprisingly strong metabolic-syndrome data.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
What people get wrong
Often saidTighter windows are always better.
ActuallyAcross trials, longer daily fasts such as 16:8 tend to produce somewhat more weight loss than 14:10, but the metabolic improvements in glucose and lipids often show no significant difference between the two. A sustained 14:10 may capture much of the benefit a person would have abandoned at a stricter window.
Often saidThe ten-hour window is proven to fix metabolic syndrome.
ActuallyThe most-cited ten-hour study (Wilkinson 2020) is a 19-person pilot with no control group. It is a signal worth following, not proof. The controlled evidence so far is associated with modest, not dramatic, change, and a 2024 randomized trial found only a small HbA1c improvement.
Often saidAny benefit comes purely from the eating window.
ActuallySeveral meta-analyses note that much of TRE's effect may come from people simply eating less when their window narrows, rather than from circadian timing itself. Finding and mechanism are not the same thing, and the timing-specific contribution remains an open question.
Who profits, and who pushes back
Weight-loss-focused practitioners
14:10 favors sustainability over depth. For people seeking faster or larger weight change, longer daily fasts tend to do somewhat more, and timing alone rarely substitutes for overall intake.
Evidence-skeptical nutrition researchers
The ten-hour window's signature study is an uncontrolled pilot, and randomized follow-ups show modest effects. Treat 14:10 as a reasonable, livable pattern, not a metabolic-syndrome treatment.
Clinicians managing medicated patients
In patients on insulin, sulfonylureas, or blood-pressure drugs, changing meal timing can shift dosing needs. Any structured fasting in this group belongs in a supervised plan, not a self-start.
Dr. Satchin Panda
Co-author of the 10-hour metabolic-syndrome study; favors sustainable windows. Research-driven.
Mainstream TRE community
Popular as a livable everyday pattern.
Where the research comes from
| Place | Share of published research |
|---|---|
| USA | 44% |
| Europe | 30% |
| Other | 26% |
Research published from: Global.
How we got here
Confining food to daylight or to a set number of hours is ancient and largely non-Western in its longest-running forms: dawn-to-sunset fasting during Ramadan, observed across the Arabian Peninsula, North Africa, South and Southeast Asia, and beyond since the seventh century, is the most widely practiced time-restricted pattern in human history, and comparable daytime-eating customs appear in many fasting traditions. The modern, measured version grew out of circadian-rhythm and chrononutrition research, where the idea that when one eats may matter alongside what one eats took shape. The specific ten-hour window entered clinical conversation through the Salk Institute and UC San Diego group around Satchin Panda and Emily Manoogian. Their 2020 Cell Metabolism pilot asked metabolic-syndrome patients, many already on statins or blood-pressure medication, to self-select a ten-hour eating window, and reported improvements without prescribed calorie cuts. That paper, single-arm though it was, gave 14:10 its identity as the sustainable, research-adjacent middle of the daily TRE spectrum, and the same lab's 2024 randomized trial in Annals of Internal Medicine carried the question into controlled territory.
- 627Dawn-to-sunset Ramadan fasting established as a daily time-restricted pattern, the oldest and most widely practiced form
- 2012Salk Institute mouse work links time-restricted feeding to protection from diet-induced metabolic disease, seeding the human research program
- 2015Early human feasibility data show most people spread eating across 14-plus hours daily, motivating windowed-eating trials
- 2020Wilkinson 2020 single-arm ten-hour pilot in metabolic-syndrome patients published in Cell Metabolism (January 7), the entry's flagship reference
- 2021Jenny Craig-based randomized trial labels a '14:10' arm and reports greater weight loss and a fasting-glucose drop versus a 12:12 comparator
- 2024Annals of Internal Medicine randomized trial of a personalized 8-to-10-hour window in metabolic syndrome finds a small HbA1c improvement versus standard counseling
- 2025Meta-analyses of TRE without calorie restriction report modest blood-pressure and glucose benefits, while flagging incidental calorie reduction as a likely driver
At a glance
- Fast window
- 14 hours
- Eating window
- 10 hours
- Evidence
- Metabolic syndrome RCT
- Sustainability
- High
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about 14:10. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
Wilkinson MJ, Manoogian ENC, Zadourian A, Panda S, et al.
Wilkinson MJ, et al.
Manoogian ENC, Panda S, et al.
Phillips NE, et al.
Thomas EA, et al.
Thai type-2-diabetes trial authors
Systematic review authors (non-diabetic adults)
Cardiometabolic TRE meta-analysis authors
WHO Eastern Mediterranean Regional Office